Revolution Medicines, Inc. RVMD Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -242.1%-40.0pp | -202.1%-28.7pp | -173.4%-13.6pp | -159.8%-5.9pp | -153.9%-0.5pp | |
| Return on invested capital | -290.8%-43.2pp | -247.5%-27.6pp | -219.9%-3.8pp | -216.1%-0.5pp | -215.5%+5.9pp | |
| Liquidity | ||||||
| Current ratio | 33.8×-6.7× | 40.4×-7.1× | 47.5×-6.2× | 53.7×-3.6× | 57.3×-5.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.4×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.2×0.0× | |
| Per Share | ||||||
| Book value per share | $34.48-9.2% | $37.96-11.5% | $42.88-2.2% | $43.83+0.2% | $43.74+1.3% | |
| Valuation | ||||||
| Market capitalization | $50.86B+33.3% | $38.16B+23.7% | $30.84B+3.9% | $29.68B+3.7% | $28.63B+4.6% | |
| Price / book | 31.8×+9.7× | 22.1×+5.9× | 16.2×+0.6× | 15.6×0.0× | 15.5×+0.1× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Revolution Medicines, Inc.'s ratios come from?
- Every ratio is computed from Revolution Medicines, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.